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Myoﬁlament calcium sensitivity decreases with frequency in intact healthy rabbit trabeculae and associates with Troponin I
and Myosin light chain-2 phosphorylation. We here tested whether serine-threonine kinase activity is primarily responsible for
this frequency-dependent modulations of myoﬁlament calcium sensitivity. Right ventricular trabeculae were isolated from New
Zealand White rabbit hearts and iontophoretically loaded with bis-fura-2. Twitch force-calcium relationships and steady state
force-calcium relationships were measured at frequencies of 1 and 4Hz at 37 ◦C. Staurosporine (100nM), a nonspeciﬁc serine-
threonine kinase inhibitor, or vehicle (DMSO) was included in the superfusion solution before and during the contractures.
Staurosporine had no frequency-dependent eﬀect on force development, kinetics, calcium transient amplitude, or rate of calcium
transient decline. The shift in the pCa50 of the force-calcium relationship was signiﬁcant from 6.05±0.04 at 1Hz versus 5.88±0.06
at 4Hz under control conditions (vehicle, P<0.001) but not in presence of staurosporine (5.89±0.08 at 1Hz versus 5.94±0.07 at
4Hz,P = NS).Phosphoproteinanalysis(Pro-QDiamondstain)conﬁrmedthatstaurosporinesigniﬁcantlybluntedthefrequency-
dependent phosphorylation at Troponin I and Myosin light chain-2. We conclude that frequency-dependent modulation of
calcium sensitivity is mediated through a kinase-speciﬁc eﬀect involving phosphorylation of myoﬁlament proteins.
1.Introduction
The relationship between heart rate and myocardial contrac-
tility has been studied extensively since Bowditch ﬁrst recog-
nized what we now refer to as the force frequency relation-
ship (FFR) [1]. Modulation of contractility through heart
rate is an intrinsic property of the heart that occurs inde-
pendent of neurohumoral activity and principally through
augmentationofcalciumhandlingandthealteringofmyoﬁl-
ament properties. In patients suﬀering from congestive
heart failure (CHF), a blunted or negative FFR is observed
regardless of the underlying etiology [2–4]. This alteration of
normal physiology likely contributes to exercise intolerance
and general lack of cardiac reserve seen in patients suﬀering
from CHF. Although a robust increase in contractility with
an increase in heart rate is a crucial regulatory property of
nonfailing myocardium in all mammals [5], its governing
underlying mechanisms are still incompletely understood.
Augmentation of the calcium transient amplitude and
rate of decline with increased frequency has been well doc-
umented [6, 7]. The mechanism underlying altered calcium
handling has been the most extensively investigated aspect of
the FFR, and several mechanisms have been suggested. It is
likely that the enhanced calcium handling is due in part, if
not exclusively, to intrinsic properties of the calcium signal-
ing system. An increase in heart rate increases the amount of
calcium entering the L-type calcium channels per unit time
and increases intracellular sodium both of which can result
in an increase in sarcoplasmic reticulum (SR) load [8, 9].
The increase in SR load results in the rise in peak systolic
calcium, resulting in enhanced myocardial force production.2 Biochemistry Research International
SR calcium reuptake rate increases due the sarcoplasmic
reticulum calcium ATPase (SERCA2a) pump working higher
on its [Ca2+]i-velocity curve. However, it is still possible
(calcium-dependent) kinase(s) are activated at higher heart
rates which could potentially augment calcium handling
through phosphorylation of the L-type calcium channel,
phospholamban, SERCA2a itself, or the ryanodine receptor.
So far the most likely candidate for a frequency dependent
phosphorylation is calcium calmodulin-dependent kinase
II (CaMKII) which has been examined in several studies
[10–12]. However, a conclusive target has yet to be found.
The roles of PKC [13], PKA [14], and PKG [15] in the
FFR have been investigated to some extent, but a conclusive
mechanismisstilllacking.Modulationofmyoﬁlamentprop-
erties with changes in heart rate has been much less investi-
gated, and the few studies that have focused on this poten-
tially contributing mechanism have, until recently, been in-
conclusive. Previous studies have found myoﬁlament cal-
cium sensitivity to be increased [16], decreased [17], and
unchanged [15] with an increase in frequency. To some
extent,thesediﬀerencesmayresideintheanimalmodelused;
in vivo, the rat and mouse depend much less on changes
in frequency (∼20% in mouse, 40–50% in rat) than larger
mammals, including humans (∼250–350%) [5, 18]. As such,
resultsobtainedinlargermammalsmaybetterreﬂecthuman
frequency-dependent behavior. We demonstrated in rabbit
right ventricular trabeculae, under near physiological condi-
tions, that myoﬁlament calcium sensitivity indeed decreases
with frequency [19]. We then proceeded to show that, in a
model of right ventricular hypertrophy [20], this frequency-
dependent myoﬁlament desensitization was impaired [21],
potentially explaining diastolic dysfunction. Moreover, we
showed that frequency-dependent myoﬁlament desensiti-
zation was associated with Troponin I and Myosin light
chain-2 phosphorylation [19, 21]. Lamberts and coworkers
recentlyshowedthat,infailingratmyocardium,afrequency-
dependent myoﬁlament desensitization also exists [13], al-
though they did not observe signiﬁcant changes in healthy
rat right ventricular trabeculae at low frequencies. Therefore,
to what extent, and in particular how, myoﬁlament calcium
sensitivity changes with frequency still remains incompletely
resolved.
Based on the previous studies, we hypothesize that a
phosphorylation event is primarily at the basis of frequency-
dependent modulation of myoﬁlament calcium sensitivity.
Using the broad-spectrum serine-threonine kinase inhibitor
staurosporine, we set out to determine a potential role of
kinases involved with the FFR. We show that the frequency-
dependent myoﬁlament desensitization is inhibited by stau-
rosporine. This ﬁnding associated with an inhibition of
frequency-dependent phosphorylation of myoﬁlament pro-
teins.
2.MaterialsandMethods
All protocols were approved by the institutional laboratory
animal care and use committee of The Ohio State University.
Male, New Zealand White (NZW) rabbits (1.5–2kg) were
given 5,000U/kg heparin iv and were anesthetized with
50mg/kg pentobarbital. The chest was opened via bilateral
thoracotomy, and the heart rapidly excised and ﬂushed ret-
rogradely with a cardioplegic Krebs Henseleit solution con-
taining 20mM 2, 3 butanedione monoxime (BDM) to pre-
vent cutting injury [22]. The right ventricle was opened and
thin,uniformtrabeculaewerecarefullydissectedandmount-
ed in a setup constructed on the stage of a Nikon-inverted
ﬂuorescent microscope as previously described [17, 19, 23,
24].
2.1. Measurement of Intracellular Calcium and Force Frequen-
cy. The cardioplegic K-H was replaced with a normal K-H
solution, and the muscle was stimulated at 1 Hz, at 37◦Ca t
an extracellular calcium concentration of 1.5mM, till con-
tractile parameters had stabilized. The muscle was then
stretchedtoanoptimallengthwherefurtherstretchingraised
diastolic and systolic force proportionally. It has been shown
that this muscle length corresponds with a sarcomere length
of around 2.2-2.3µm[ 25]. For loading of the indicator, tem-
perature was temporarily dropped to 23◦C to facilitate the
loading process. Trabeculae were iontophoretically loaded
with the calcium indicator bis-fura 2 as described previously
fortheindicatorfura-2[24].Theloadingproceduretypically
lasted between 15 and 25 minutes. We have shown that
the kinetics of this indicator, even at body temperature, are
suﬃciently fast to accurately track the calcium transient even
at the highest frequency [26]. After returning to 37◦C, a
controlforce-frequencyrelationshipwasdeterminedoneach
muscle by stimulating the muscle to twitch for 2 minutes
(more than suﬃcient to reach steady state), at 1, 2, 3, and
4Hz. Force tracings and ﬂuorescentemissions at 340 nm and
380 nm were collected. The stimulation was returned to 1 Hz
and either DMSO(0.01%v/v) or staurosporine (0.1µM)was
added to the superfusion solution and allowed to circulate
for 5 minutes before a second force-frequency was measured
(same protocol as control). The 0.1µM concentration of
staurosporine was chosen because it is at least 5 times the in
vitro Ki for the most obvious candidate kinases (PKA 15nM,
PKC 5nM, PKG 18nM, CaMKII 20nM and MLCK 21nM)
[27] while still below the concentration where some of the
nonspeciﬁceﬀectsofstaurosporinehavebeenfoundtooccur
[27].
2.2. Measurement of Steady-State Myoﬁlament Activation. To
obtain a steady-state myoﬁlament calcium sensitivity rela-
tionship at 37◦C, we employed potassium-induced con-
t r a c t u r e sa sd e s c r i b e dp r e v i o u s l y[ 19, 28, 29]. Immediately
after the second force-frequency measurement, trabeculae
under the inﬂuence of staurosporine or vehicle control were
stimulated to contract at 1 or 4Hz. The superfusion solution
was switched from regular Krebs Henseleit solution to one
with a modiﬁed Na/K balance (6mM Ca2+ 110mMK+ and
40mM Na+). Bis-fura 2 ﬂuorescent emission ratios were
collected along with force till the peak of the contracture.
The ﬂuorescence signal ratio of 340/380 was converted into
[Ca2+]i by obtaining the minimum and maximum ratios
(Rmin and Rmax) as described previously [24]. The [Ca2+]i
values were plotted against force, and the data was ﬁt-
ted using the Hill equation. In each muscle, a potassiumBiochemistry Research International 3
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Figure 1:Panels(a),(b),and(c)showrepresentativecalciumtransients(a),forcetracings(b),andcorrespondingphaseplaneplots(c)from
rabbit right ventricular trabeculae stimulated to contract at 1, 2, 3, and 4Hz (37◦C). Note the shift to the right of the relaxation trajectory of
the phase plane plots. The same preparation was then treated with 100nM staurosporine and the protocol repeated. Calcium transients (d),
force tracings (e), and the resulting phase planes (f) are shown. Note the elimination of the relaxation trajectory shift after the addition of
staurosporine.
contracture was performed at 1 and 4Hz under the inﬂuence
of either staurosporine or vehicle. Muscle length was held
constantbetweenthetwomeasurementstoensuresarcomere
l e n g t hw a se x c l u d e da sac a u s ei nm y o ﬁ l a m e n tc a l c i u ms e n -
sitivity shift between the two frequencies. Therefore, paired
comparisons were made between the two frequencies with or
withoutstaurosporine(n = 10DMSO,n = 9staurosporine).
2.3. Measuring Protein Phosphorylation (Pro-Q Diamond
Stain). Phosphoprotein analysis via the Pro-Q Diamond
Stain wasperformed as described previously [19, 29]. Brieﬂy,
trabeculae twitching at either 1 or 4Hz with either DMSO or
0.1µM staurosporine in the superfusion bath were doused
with liquid nitrogen until frozen and rapidly removed from
the experimental setup. The tissue was then homogenized
in an SDS protein lysis buﬀer and loaded on a 15% 8 ×
10cm SDS-PAGE gel (1.5mm thickness, 4% stacking gel,
15 wells). The gel was then run for 45 minutes at 175V.
The gel was ﬁxed overnight and stained using the Pro-
Q Diamond phosphoprotein stain (Invitrogen). Following
staining and destaining, the gel was imaged in a Typhoon
variable mode scanner (GE Healthcare) using an excitation
wavelength of 532nm and a 610nm (BP30) emission ﬁlter at
a photomultiplier setting of 450nm. After imaging, the gel
was washed in water for 1 hour and stained for total protein
with Sypro Ruby protein stain (Invitrogen). Following stain-
ing and destaining, the gel was imaged in a Typhoon scan-
ner using an excitation wavelength of 488nm and a 610nm
(BP30) emission ﬁlter at a PMT setting of 425nm. Densito-
metric analysis was performed on each band, and the ratio
of Pro-Q stain intensity to total protein intensity was calcu-
lated.
2.4. Statistics. Data was analyzed using paired two tailed t-
tests for sensitivity curves where P<0.05 was considered
signiﬁcant.Averagedataispresentedwitherrorbarsshowing
standard error of the mean. Two- and one-way ANOVAs
with post hoc t-tests (Bonferroni correction) were used for
analysis of twitch and calcium transient data.
3. Results
Figure 1 shows an experiment where a force frequency rela-
tionship was obtained before and after the addition of stau-
rosporine to the superfusate. As previously shown [19, 21],4 Biochemistry Research International
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Figure 2: Average twitch and calcium transient data from trabeculae treated with staurosporine or vehicle (DMSO) (n = 8 for each group).
Panels (a) and (b) show the developed force (a) and relaxation time to 90% of peak (RT50)a te a c hf r e q u e n c y1t h r o u g h4H z .A n a l y s i s
by two-way ANOVA (Bonferroni correction, P<0.05) showed that frequency signiﬁcantly altered force and relaxation, but staurosporine
did not signiﬁcantly alter the FFR or FDAR. Panels (c) and (d) show the average systolic calcium levels (c) and time constant of calcium
decline (tau). There was no signiﬁcant eﬀect of 100nM staurosporine, nor an interaction between staurosporine and frequency. The eﬀect
of frequency within each group was analyzed by one-way AVOVA (∗signiﬁcantly diﬀerent from 1Hz).
under control conditions, the relaxation trajectory of the
phase plane plots of [Ca2+]i versus force shifts to the right
withanincreaseinfrequency,suggestingmyoﬁlamentdesen-
sitization. The phase-plane plots allow for the determination
of calcium versus force relationship trajectories independent
of timing [23, 30, 31]. We observed that, with the addition
of staurosporine the relaxation trajectories line up, that is no
shift is observed. Although this is an indirect assessment, this
suggests that staurosporine was able to inhibit frequency-
dependent myoﬁlament desensitization.
Figure 2 shows average data for developed force (Fdev),
time from peak tension to 50% relaxation (RT50 force),
systolic calcium concentration (nM), and the RT50 of cal-
ciumdecline(RT50 calcium).Developedforceincreasedwith
frequency in both control and staurosporine groups when
stimulation frequency is increased. Statistical analysis (2-way
ANOVA) revealed no signiﬁcant eﬀect of staurosporine on
any force, or calcium-transient parameter.
Next, we set out to determine if staurosporine had an
eﬀectonmyoﬁlamentcalciumsensitivitymodulationsdueto
frequency. For this, we employed so called “potassium con-
tractures” to introduce a pseudo-steady state between the
intracellular calcium concentration and developed force in
order to measurethe calciumsensitivity of the myoﬁlaments.
Figure 3(a) shows the original data of a representative po-
tassium contracture. The superfusate solution is rapidly
switched from normal Krebs-Henseleit solution to one con-
taining high potassium and low sodium (indicated by the
grey area in the ﬁgure). Upon application of the “potassium
contraction” solution, calcium enters the cytoplasm slowly,
inducing a slowing forming contracture. By rapidly switch-
ing between 340nm and 380nm excitation wavelengths,Biochemistry Research International 5
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Figure 3: Figure 3 shows a representative acquisition and analysis of the force-calcium relationship. Panel (a) shows the chart of a potassium
contracture. The trabecula in this example is twitching at 1Hz (top of panel) when the superfusate solution is rapidly switched from normal
Krebs Henseleit solution to that with a higher potassium and lower sodium concentration. Diastolic calcium (lower panel) is measured by
rapidly switching the excitation wavelength between 340 and 380nm. After the potassium solution is washed out, the contracture relaxes
and the muscle recovers. Panels (b) and (c) show representative force pCa relationships obtained in trabeculae twitching at 1 or 4Hz with
vehicle (b) or staurosporine (c) in the superfusate solution.
diastolic calcium was measured as this contracture formed,
up till peak force had developed. Thereafter, the perfusate
was switched back to the normal Krebs-Henseleit solution,
and the membrane potential slowly reestablished, while cal-
cium is removed from the cytosol, and subsequently the con-
tracture dissipates. The simultaneously recorded force and
bis-fura-2 ratio data allows us to construct a myoﬁlament
calcium sensitivity relationship, from which characterizing
parameters are determined by ﬁtting this data with the Hill
equation. Figures 3(b) and 3(c) show an example of [Ca2+]i
versus. force curves derived from control and staurosporine
protocols. A potassium contracture was performed at 1 and
4Hz for each muscle.
Figure 4showstheaverageforparameterspCa50 andFmax
for control and staurosporine. While there was a signiﬁcant
desensitization with respect to the pCa50 from 1 to 4Hz in
the control group, in line with our previous observations,
no such frequency-dependent shift was detected with stau-
rosporine. Maximum developed force of each potassium
contracture (Fmax) was not signiﬁcantly (P>0.05) diﬀerent
between each group although the diﬀerence in average
Fmax between 1 and 4Hz in the control group approached
signiﬁcance (P<0.1). The hill coeﬃcient, an indicator of
cooperativity of the myoﬁlament force response, was not sig-
niﬁcantly diﬀerent between control and staurosporine sen-
sitivity curved (NHill; control: 1Hz 3.99 ± 0.60, 4Hz 2.82 ±
0.56; staurosporine: 1Hz 2.28 ± 0.38, 4Hz 2.0 ± 0.18).
Figure 5 shows a section of an SDS gel stained for total
protein (a) (Sypro ruby) and phosphoprotein (b) (Pro-Q
Diamond) at the location corresponding with Troponin I
(TnI) and Myosin light chain-2 (MLC-2). The average ratio
of band density of phosphoprotein to total protein for TnI
(c) and MLC-2 (d) is also depicted. A signiﬁcant increase
in the ratio was found for TnI between 1 and 4Hz in the6 Biochemistry Research International
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Figure 4: Average pCa50 and maximum force (Fmax) data obtained from the force calcium relationships (n = 10 for DMS and n = 9f o r
staurosporine). A signiﬁcant diﬀerence (P<0.05 denoted with ∗)w a ss e e ni nt h ep C a 50 and Fmax between the 1 and 4Hz under control
conditions (panels (a) and (b)). These shifts in sensitivity and Fmax were eliminated by staurosporine (panels (c) and (d)).
control group consistent with previous ﬁndings [19]. The
diﬀerence in ratio between 4Hz with staurosporine and 4Hz
with DMSO was also found to be signiﬁcantly diﬀerent. The
diﬀerence in ratio of phosphoprotein to total protein for
MLC-2 approached signiﬁcance between 1 and 4Hz for the
control group (P<0.1b u t>0.05). However, a signiﬁcant
diﬀerence in MLC-2 phosphorylation was found between
4Hz staurosporine and 4HzDMSO.
4. Discussion
In this study, we investigated whether frequency-dependent
myoﬁlament desensitization is mediated by a kinase depen-
dent pathway and how this phenomenon impacts cardiac
trabecular twitch contractions. We now show for the ﬁrst
time that broad-spectrum serine-threonine kinase inhibi-
tion inhibits frequency-dependent myoﬁlament desensitiza-
tion. Staurosporine was able to inhibit frequency-induced
phosphorylation of TnI which is likely (at least partially)
responsible for frequency-dependent myoﬁlament desensi-
tization. We also show that staurosporine does not, at the
concentration used in our studies, aﬀect the dynamics of
the calcium transient or its relationship to stimulation rate.
From this, we conclude serine threonine kinase pathways
activatedwithchangesinfrequencymainly,ifnotexclusively,
modulate myoﬁlament function, but not calcium transient
regulation. Although changes in phosphatase activity cannot
be excluded at this point, the near-complete abolishment of
frequency-dependent changes in myoﬁlament calcium sen-
sitivity indicate that phosphatases likely play only a minor, if
any, role.
Despite extensive research, the molecular mechanisms of
frequency-dependent augmentation calcium handling and
modulations of myoﬁlament calcium sensitivity have eluded
full understanding. This is not entirely surprising, as fre-
quency modulation occurs in vivo during a highly dynamic
response. Governing factors such as calcium concentration,
external mechanical load, internal passive-elastic elements,
and ionic ﬂuxes never reach a steady state balance. Thus,
a steady-state snap shot of these parameters or interactions
can never fully describe the prevailing dynamical situation.
Using our approach, we found that staurosporine, at aBiochemistry Research International 7
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Figure 5: Analysis of TnI and MLC-2 phosphorylation status in muscles stimulated to twitch at 1 or 4Hz, with and without staurosporine.
Panel (a) shows a representative SDS gel stained for total protein using the Sypro Ruby protein stain. Panel (b) shows the same gel
counterstained for phosphoprotein using the Pro-Q Diamond Stain. Densitometric analysis of bands corresponding to TnI and MLC-2
was obtained from each stain and the ratio of phosphoprotein to total protein calculated for each group. TnI phospho/total protein ratio is
shown in panel (c) and MLC-2 shown in panel (d) (n = 4 for each group, other gel not shown); error bars are SEM, ∗P<0.05 considered
signiﬁcant.
concentration where several major kinases are inhibited, had
no eﬀect on the frequency dependency of the calcium tran-
sient amplitude or decline, nor force amplitude or decline.
This data suggests that changes in frequency do not induce
phosphorylations that aﬀect the calcium transient itself. This
ﬁnding is consistent with Kassiri et al. where the use of
broadspectrumkinaseinhibitorK252-ayieldednochangein
the frequency-dependent augmentation of calcium handling
[15].Althoughwecannotexcludephosphorylationeventsdo
occur with frequency on key calcium handling proteins, our
results indicate that, if they do occur, their functional eﬀect
on the cytosolic calcium transient appears to have little or
no functional signiﬁcance. Other studies have focused on the
speciﬁc eﬀect of CaMKII [11, 32] as a potential regulator
of calcium handling dynamics. Most recently, Picht and
coworkers [12] found that CaMKII inhibition directed to
the SR inhibits frequency-dependent acceleration of calcium
decline by inhibiting, an increase in SERCA2a Vmax. While,
in the present study we did not measure or derive SERCA
velocity measurements, we did ﬁnd that the RT50 of calcium
decline was not diﬀerent between control and staurosporine.
This thus suggests that intracellular calcium decline, which
can be impacted by the calcium transient amplitude itself
[33], was not signiﬁcantly blunted with kinase inhibition
under the present experimental conditions, which were very
close as they prevail in vivo regarding mechanical load,
temperature, and stimulation range. Clearly, our data here
suggest that the intrinsic properties, rather than frequency-
induced phosphorylations, of the calcium handling system
p l a yam a j o r( i fn o tt h eo n l y )r o l ei na u g m e n t a t i o no f
amplitude and rate of decline.
A striking eﬀect of staurosporine was the complete elim-
ination of the frequency-dependent shift in myoﬁlament cal-
cium sensitivity from 1 to 4Hz. In addition, there appears to
(possibly) be an eﬀect of frequency on maximal developed
force. Although this shift in Fmax did not quite reach8 Biochemistry Research International
signiﬁcance (P<0.1b u t>0.05), there may still be a kinase-
dependent eﬀect on Fmax. Supporting this speculation is the
fact that in the staurosporine group, there was almost no
variability in the myoﬁlament sensitivity curve Fmax. These
data show that changes in stimulation frequency activate sig-
naling pathways that lead to the activation of protein kinases,
w h i c hi nt u r na ﬀect myoﬁlament calcium sensitivity and
possibly Fmax. Since these eﬀects were completely eliminated
by staurosporine, it is likely that phosphorylation events
comprise most, if not all, of the mechanism responsible for
frequency-dependent changes in myoﬁlament function. This
data was veriﬁed using a phosphoproteomics protocol. We
show that TnI is hyperphosphorylated at higher frequency,
in line with our previous observation [19]. Staurosporine
inhibited this hyperphosphorylation, and we observed that
the relative TnI phosphorylation levels were lower than
those in the absence of staurosporine at 1Hz, indicating
that even, at the lowest frequency baseline, phosphorylation
of TnI is present. Despite the clear eﬀect of staurosporine
on myoﬁlament calcium sensitivity, staurosporine induced
no signiﬁcant interaction between frequency and the twitch
parameters measured. Frequency-dependent acceleration of
relaxation (FDAR) was still mostly intact. This paradigm
may be explained by the fact that staurosporine may have
inhibited more than one pathway which can have opposite
eﬀectsonmyoﬁlamentcalciumsensitivityandtwitchparam-
eters. We found that staurosporine signiﬁcantly reduced TnI
and MLC-2 phosphorylation at 4Hz, compared to control
but not at 1Hz. It has been shown by many investigators
that TnI phosphorylation can decrease myoﬁlament calcium
sensitivity [34–36]. Also, it has been shown that MLC-2
phosphorylation can increase myoﬁlament calcium sensi-
tivity [37–39]. Therefore, we should not necessarily expect
the eﬀect of staurosporine on the twitch parameters to be
straightforward. The pCa50 values attained by potassium
contractures reveal that staurosporine, while inhibiting the
shift in pCa50, set the myoﬁlament sensitivity to level be-
tween that of 1 and 4Hz in the control group 4Hz. With
sensitivity set to a slightly lower value, the rate-limiting step
of relaxation may begin to favor other factors such as the
rate of calcium decline, including Troponin-C calcium oﬀ-
rate kinetics [40, 41] and calcium-regulated SERCA-activity
[33]. In addition, MLC-2 phosphorylation has been shown
to slow cross bridge kinetics [42] which would counter the
acceleratory eﬀect of TnI phosphorylation. Abolishment of
both of these may have a null eﬀect on relaxation. Finally, it
hasbeenpreviouslyspeculatedshiftsinmyoﬁlamentcalcium
sensitivity do not inﬂuence the actual rate of relaxation to a
large extent [43], and recent views on contraction-relaxation
coupling have postulated an overall governing mechanical
rate that may impact contractile kinetics as a whole and not
be speciﬁc to relaxation [44, 45].
Although for certain compounds speciﬁc inhibitors exist
that work well in a test tube with a limited number of sub-
strates, recent pilot experiments revealed that compounds
such as for instance ML7 (an inhibitor of MLC2) have
drastic side eﬀects on the calcium transients, and thus likely
have multiple targets in the myocyte, to the extent that the
muscle barely contracts, and prohibited an unambiguous
investigation of contractile properties in present of this com-
pound. As the study of frequency-dependent activation
requires an intact preparation, future studies in which the
speciﬁcity of kinases is extensively documented in such an
integrated preparation may aid to reveal the exact identiﬁca-
tion of the speciﬁc kinase responsible. For instance, CaMKII
could be a potential mediator, since the increase in calcium
during high frequencies may activate this pathway. On the
otherhand,thetimecourseofCaMKIIactivationmaybetoo
slow [46] to be critically involved in frequency-dependent
desensitization, but, at present, the complete elucidation of
pathway and speciﬁc amino acid targets is deemed beyond
the scope of this study. Furthermore, we and others showed
the importance of frequency-dependent as well as the role
of TnI in hypertrophy [21] and aging [47], and thus future
elucidationofspeciﬁckinasesandspeciﬁctargetswouldbeof
signiﬁcant importance, as would be to resolve the temporal
resolution of the changes in myoﬁlament responsiveness
upon a change in frequency.
In summary, we have shown that broad-spectrum kinase
inhibition has no signiﬁcant eﬀect on calcium transient am-
plitude and rate of decline, or how these parameters change
with frequency. Frequency-dependent shifts in myoﬁlament
calciumsensitivityarehowevervirtuallyabolishedwithstau-
rosporine, suggesting the kinase-dependent augmentation of
the force frequency appears to primarily target the myoﬁl-
aments, whereas the frequency-dependent augmentation of
the calcium transient mainly relies on its intrinsic properties.
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